Abstract
Preliminary results on human subjects with breast cancer undergoing neoadjuvant chemotherapy suggest early changes in blood flow measured with diffuse correlation spectroscopy may serve as a potential predictor for therapeutic efficacy.
© 2012 Optical Society of America
PDF ArticleMore Like This
Regine Choe, Turgut Durduran, So Hyun Chung, Soren D. Konecky, Saurav Pathak, Han Y. Ban, David R. Busch, Erin M. Buckley, Meeri N. Kim, Angela DeMichele, Carolyn Mies, Mark A. Rosen, Mitchell D. Schnall, and Arjun G. Yodh
BSuB2 Biomedical Optics (BIOMED) 2010
Regine Choe, Gabriel Ramirez, Ashley R. Proctor, Songfeng Han, Turgut Durduran, and Edward B. Brown
CTu4A.4 Cancer Imaging and Therapy (Cancer) 2016
Jeffrey M Cochran, So Hyun Chung, Anais Leproux, Wesley B Baker, David R Busch, Bruce J Tromberg, and Arjun G Yodh
OW2D.5 Optical Tomography and Spectroscopy (OT&S) 2018